| KalVista Pharmaceuticals, Inc. KALV | $48.93M | 9.78 | 4.13M | +19.91% | +$8.12M | 0.19 | |
| Precision BioSciences, Inc. DTIL | $7.99M | 8.51 | 589,569 | -82.66% | -$38.11M | 0.03 | |
| CytomX Therapeutics, Inc. CTMX | $14.06M | 8.28 | 6.45M | -1.53% | -$218,000.00 | 0.06 | |
| Adicet Bio, Inc. ACET | $15.06M | 7.8 | 6.41M | +631.14% | +$13M | 0.06 | |
| Outlook Therapeutics, Inc. OTLK | $19.34M | 6.92 | 1.62M | New | +$19.34M | 0.08 | |
| Evolus, Inc. EOLS | $58.06M | 6.62 | 4.15M | +33.9% | +$14.7M | 0.23 | |
| Tarsus Pharmaceuticals, Inc. TARS | $81.96M | 5.97 | 2.25M | +2.27% | +$1.82M | 0.32 | |
| Elevation Oncology, Inc. ELEV | $15.7M | 5.6 | 3.06M | -16.57% | -$3.12M | 0.06 | |
| AnaptysBio, Inc. ANAB | $29.97M | 4.87 | 1.33M | -31.77% | -$13.96M | 0.12 | |
Atea Pharmaceuticals, Inc. AVIR | $16.47M | 4.84 | 4.08M | 0% | +$0 | 0.07 | |
| Ventyx Biosciences, Inc. VTYX | $17.05M | 4.4 | 3.1M | +55% | +$6.05M | 0.07 | |
| Altimmune, Inc. ALT | $28M | 3.88 | 2.75M | 0% | +$0 | 0.11 | |
| Vanda Pharmaceuticals Inc. VNDA | $7.2M | 3.01 | 1.75M | +605.77% | +$6.18M | 0.03 | |
| Black Diamond Therapeutics, Inc. BDTX | $8.13M | 2.85 | 1.6M | -11.09% | -$1.01M | 0.03 | |
| Mirum Pharmaceuticals, Inc. MIRM | $29.82M | 2.52 | 1.19M | +4.4% | +$1.26M | 0.12 | |
LENZ Therapeutics, Inc. LENZ | $12.23M | 2.15 | 547,616 | New | +$12.23M | 0.05 | |
| Applied Therapeutics, Inc. APLT | $15.16M | 1.95 | 2.23M | New | +$15.16M | 0.06 | |
| Zymeworks Inc. ZYME | $11.57M | 1.56 | 1.1M | 0% | +$0 | 0.05 | |
| Nuvation Bio Inc. NUVB | $12.93M | 1.44 | 3.55M | +1.48% | +$188,784.96 | 0.05 | |
| Aurinia Pharmaceuticals Inc. AUPH | $10.27M | 1.43 | 2.05M | +272.73% | +$7.51M | 0.04 | |
| Immunome, Inc. IMNM | $17.77M | 1.2 | 720,000 | New | +$17.77M | 0.07 | |
CARGO Therapeutics, Inc. Common Stock CRGX | $10.42M | 1.19 | 466,809 | +190.77% | +$6.84M | 0.04 | |
| Avadel Pharmaceuticals plc AVDL | $17.69M | 1.09 | 1.05M | -2.99% | -$544,753.18 | 0.07 | |
| Viridian Therapeutics, Inc. VRDN | $12.13M | 1.09 | 692,925 | 0% | +$0 | 0.05 | |
| Cullinan Oncology, Inc. CGEM | $9.73M | 0.99 | 571,138 | -25.94% | -$3.41M | 0.04 | |
| PTC Therapeutics, Inc. PTCT | $20.36M | 0.91 | 700,000 | -22.22% | -$5.82M | 0.08 | |
Dianthus Therapeutics, Inc. DNTH | $7.94M | 0.9 | 264,692 | -47.51% | -$7.19M | 0.03 | |
Immunocore Holdings plc IMCR | $26.36M | 0.81 | 405,600 | 0% | +$0 | 0.1 | |
| Rocket Pharmaceuticals, Inc. RCKT | $17.78M | 0.73 | 660,000 | +164% | +$11.05M | 0.07 | |
| ANI Pharmaceuticals, Inc. ANIP | $10.37M | 0.72 | 150,000 | New | +$10.37M | 0.04 | |
| Kiniksa Pharmaceuticals, Ltd. KNSA | $9.87M | 0.71 | 500,000 | -16.67% | -$1.97M | 0.04 | |
Deciphera Pharmaceuticals, Inc. DCPH | $9.44M | 0.69 | 600,000 | New | +$9.44M | 0.04 | |
MorphoSys AG MOR | $14.52M | 0.53 | 800,705 | New | +$14.52M | 0.06 | |
| Harmony Biosciences Holdings, Inc. HRMY | $9.44M | 0.5 | 281,200 | +3.69% | +$335,800.00 | 0.04 | |
| ACADIA Pharmaceuticals Inc. ACAD | $9.59M | 0.31 | 518,900 | +353.58% | +$7.48M | 0.04 | |
| Vaxcyte, Inc. PCVX | $20.49M | 0.28 | 300,000 | 0% | +$0 | 0.08 | |
| Arvinas, Inc. ARVN | $7.43M | 0.26 | 180,000 | +125% | +$4.13M | 0.03 | |
| Iovance Biotherapeutics, Inc. IOVA | $7.41M | 0.18 | 500,000 | -50% | -$7.41M | 0.03 | |
Apogee Therapeutics, Inc. APGE | $6.64M | 0.17 | 100,000 | New | +$6.64M | 0.03 | |
Biohaven Pharmaceutical Holding Company Ltd. BHVN | $7.66M | 0.16 | 140,000 | 0% | +$0 | 0.03 | |
| Intra-Cellular Therapies, Inc. ITCI | $10.38M | 0.14 | 150,000 | -31.82% | -$4.84M | 0.04 | |
| CRISPR Therapeutics AG CRSP | $7.94M | 0.14 | 116,500 | -45.81% | -$6.71M | 0.03 | |
| Ionis Pharmaceuticals, Inc. IONS | $6.5M | 0.1 | 150,000 | -25% | -$2.17M | 0.03 | |
| Viking Therapeutics, Inc. VKTX | $8.2M | 0.09 | 100,000 | New | +$8.2M | 0.03 | |
| Cytokinetics, Incorporated CYTK | $7.01M | 0.09 | 100,000 | -9.09% | -$701,100.00 | 0.03 | |
GSK plc GSK | $12.86M | 0.01 | 300,000 | 0% | +$0 | 0.05 | |
AstraZeneca PLC AZN | $10.16M | 0.01 | 150,000 | -11.77% | -$1.35M | 0.04 | |
| Eli Lilly and Company LLY | $21M | <0.01 | 27,000 | -10% | -$2.33M | 0.08 | |
| NVIDIA Corporation NVDA | $9.04M | <0.01 | 10,000 | New | +$9.04M | 0.04 | |
| Inhibrx, Inc. INBX | $24.47B | <0.01 | 700,000 | New | +$24.47B | 96.33 |